Vault-13

EUCRATES BIOMEDICAL ACQU COR

UNIT 10/23/2027 · CUSIP G3141W114

0 institutional holders -5 vs Q1 2023
—reported value*
0 new 0 added 0 reduced 5 sold out net sold ≈ $6.7m (-649.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2023

Institutional holders

Managers reporting a position, each quarter

051015Q3 22: 14Q4 22: 7Q1 23: 5Q2 23: 00Q3 22Q4 22Q1 23Q2 23
Numbers
QuarterHolders
Q3 202214
Q4 20227
Q1 20235
Q2 20230

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q4 22: 2 bought or addedQ4 22: 11 cut or sold outQ4 22Q1 23: 1 bought or addedQ1 23: 2 cut or sold outQ1 23Q2 23: 0 bought or addedQ2 23: 5 cut or sold outQ2 23
Numbers
QuarterBought or addedCut or sold out
Q4 2022211
Q1 202312
Q2 202305

Biggest buyers

None

Biggest sellers

Verition Fund Management LLC Sold out -397,603-397.6k
Sio Capital Management, LLC Sold out -248,674-248.7k
CLEAR STREET LLC Sold out -2,740-2.7k
DEERFIELD MANAGEMENT COMPANY, L.P. Sold out -1-1
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Sold out +00

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change